Share on StockTwits

Stryker (NYSE:SYK) released its earnings data on Thursday. The company reported $1.08 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.08, American Banking & Market News reports. The company had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.35 billion.

In other Stryker news, Director Ronda E. Stryker sold 14,000 shares of Stryker stock on the open market in a transaction that occurred on Tuesday, July 15th. The shares were sold at an average price of $82.77, for a total transaction of $1,158,780.00. The sale was disclosed in a document filed with the SEC, which is available at this link.

Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Stryker in a research note on Thursday, July 10th. They now have a $88.00 price target on the stock. On the ratings front, analysts at Cantor Fitzgerald raised their price target on shares of Stryker from $78.00 to $84.00 in a research note on Tuesday, July 1st. Finally, analysts at Argus upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Wednesday, June 11th. They now have a $102.00 price target on the stock. Eight research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $83.22.

Stryker (NYSE:SYK) traded down 0.72% on Thursday, hitting $81.70. 1,725,202 shares of the company’s stock traded hands. Stryker has a one year low of $66.44 and a one year high of $86.93. The stock’s 50-day moving average is $84.45 and its 200-day moving average is $80.82. The company has a market cap of $30.972 billion and a P/E ratio of 40.76.

Stryker Corporation (NYSE:SYK) is a medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.